Document Detail


Acute leukemia during pregnancy. Association with immune-mediated thrombocytopenia in mother and infant.
MedLine Citation:
PMID:  1691571     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A 29-year-old female in the 20th week of pregnancy was admitted because of a change in the ABO blood group and bleeding tendency. Acute myelogenous leukemia was diagnosed with a weak reaction of red blood cells with anti-A antibody and a decreased level of A-transferase activity. Though the patient tolerated intensive chemotherapy and achieved complete remission, thrombocytopenia persisted after consolidation chemotherapy. Since platelet-associated IgG was elevated, thrombocytopenia was considered to be immune-mediated. In the third trimester, premature separation of the normally implanted placenta developed and cesarean section was performed. The male baby was also thrombocytopenic, but successfully treated with gamma-globulin.
Authors:
H Gondo; Y Hamasaki; H Nakayama; T Kondo; J Mitsuuchi; Y Kawaga; S Taniguchi; M Harada; Y Niho
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Acta haematologica     Volume:  83     ISSN:  0001-5792     ISO Abbreviation:  Acta Haematol.     Publication Date:  1990  
Date Detail:
Created Date:  1990-05-21     Completed Date:  1990-05-21     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0141053     Medline TA:  Acta Haematol     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  140-4     Citation Subset:  IM    
Affiliation:
Division of Internal Medicine, Sanshinkai Hara Hospital, Fukuoka, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abruptio Placentae / etiology
Adult
Cesarean Section
Female
Humans
Infant, Newborn
Leukemia, Myeloid, Acute / blood*,  drug therapy
Male
Pregnancy
Pregnancy Complications, Hematologic / etiology*,  therapy
Pregnancy Complications, Neoplastic / blood*,  drug therapy
Pregnancy Trimester, Third
Thrombocytopenia / congenital,  etiology*,  therapy
gamma-Globulins / therapeutic use
Chemical
Reg. No./Substance:
0/gamma-Globulins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  High-fat feeding induces tissue-specific alteration in proportion of activated insulin receptors in ...
Next Document:  Comparison of three silver stains for demonstrating neurofibrillary tangles and neuritic plaques in ...